CMI_LatestReportOrientedBlogs

  PET-CT Scanner Device  During a single imaging session, a positron emission tomography (PET) - computed tomography (CT) scan exposes information on the structure and function of cells and tissues in the body. In recent years, the bulk of PET scans have been done using devices that combine PET and CT scanners. The PET-CT scans together provide pictures that show the anatomic site of aberrant metabolic activity in the body. The results of the combined scans have been found to be more accurate than the results of the two scans taken separately. According to Coherent Market Insights, The global PET-CT scanner device market size was valued at US$ 1.9 billion in 2017 and is expected to witness a CAGR of 5.1% over the forecast period (2018 – 2026). PET and CT scans are used to diagnose a variety of ailments, including cancer, heart disease, and some brain abnormalities. PET scanners detect metabolic activity, while CT scanners reveal anatomical details. The danger of improper superimposi

  Tissue engineering Tissue engineering emerged from the field of biomaterials development. Tissue engineering aims to create functional constructions that can be used to restore, maintain, or improve damaged tissues or complete organs. Engineered tissues such as artificial skin and cartilage have been approved by the FDA, but their application in human patients is currently limited. Tissue engineering entails the in vitro creation of bioartificial tissues as well as the in vivo manipulation of cell growth and function using cells isolated from donor tissue and biocompatible scaffold materials. To facilitate effective cell adhesion, migration, and deposition of endogenous extracellular matrix components by the cells, biomaterials for tissue engineering must have regulated surface chemistry, porosity, and biodegradability. To create a large cell mass that can perform certain differentiated roles required for the tissue build, strategies to switch cells between growth and differentiat

  Optogenetics Optogenetics can be an emerging medical technique, which involves the usage of light to manage cells in living tissues, especially neurons to greatly help study the characteristics of normal and abnormal brain function. Optogenetics can be an emerging field of biotechnology trending among the fields of neuroscience, cardiology, ophthalmology, behavioral science, and other healthcare domains. The technique is widely used to deal with neurological disorders such as for instance depression. Depression is caused by chronic stress that creates a series of negative memories. Key players in the Optogenetics market include Coherent, Inc., Thorlabs, Inc. Cobalt, Inc., Scientifica, Laserglow Technologies, Regenxbio, Inc., Gensight, Addgene, UPenn Vector Core, and Jackson Laboratories. The main element players are focusing on strategic mergers and acquisitions and development of innovative systems. For example, Coherent Inc. launched a brand new kind of short pulse ultrafast lase